E22 General Considerations for Patient Preference Studies
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 6, 2026
February 5, 2026
3b39fdd6-9dd0-4536-9f4d-dc3bddcc1267
Related Documents
M4Q(R2) The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality
Guidance DocumentJanuary 20, 2026Center for Drug Evaluation and Research
Q3E Guideline for Extractables and Leachables
Guidance DocumentNovember 28, 2025Center for Drug Evaluation and Research
E20 Adaptive Designs for Clinical Trials
Guidance DocumentSeptember 30, 2025Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.